Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04499053
Title Durvalumab in Combination With Chemotherapy in Virus-infected Patients With Non-small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Georgetown University
Indications

lung non-small cell carcinoma

Therapies

Carboplatin + Durvalumab + Paclitaxel

Carboplatin + Durvalumab + Nab-paclitaxel

Cisplatin + Durvalumab + Pemetrexed Disodium

Carboplatin + Durvalumab + Pemetrexed Disodium

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST